Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats

Journal of Clinical Neuroscience

Volumn 15, Issue 6, 2008, Pages 665-671

  Çolak, Ahmet ^a   Kelten, Bilal ^a   Saǧmanligil, Ayhan ^a   Akdemir, Osman ^a   Karaoǧlan, Alper ^a   Şahan, Elife ^a   Çelik, Özge ^b   Barut, Şeref ^a  

^a ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL KULTUR UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Caspase 9; Caspase inhibitor; Cytochrome c; Secondary damage; Spinal cord injury; Tauroursodeoxycholic acid

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; TAUROURSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; MOTOR PERFORMANCE; NERVOUS SYSTEM INJURY; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; STATISTICAL SIGNIFICANCE; TISSUE INJURY;

ANIMALS; APOPTOSIS; CHOLAGOGUES AND CHOLERETICS; DISEASE MODELS, ANIMAL; IN SITU NICK-END LABELING; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; STATISTICS, NONPARAMETRIC; TAUROCHENODEOXYCHOLIC ACID; TIME FACTORS;

EID: 43049096711     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.06.002     Document Type: Article

References (46)

1. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 (1972) 239-257
2. Raff M. Cell suicide for beginners. Nature 396 (1998) 119-122
3. Samali A., Zhivotovsky B., Jones D., et al. Apoptosis: cell death defined by caspase activation. Cell Death Differ 6 (1999) 495-496
4. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
5. Kato H., Kanellopoulos G.K., Matsuo S., et al. Neuronal apoptosis and necrosis following spinal cord ischemia in the rat. Exp Neurol 148 (1997) 464-474
6. Lu J., Ashwell K.W., and Waite P. Advances in secondary spinal cord injury: role of apoptosis. Spine 25 (2000) 1859-1866
7. Barut S., Unlu Y.A., Karaoglan A., et al. The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats. Surg Neurol 64 (2005) 213-220
8. Casha S., Yu W.R., and Fehlings M.G. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103 (2001) 203-218
9. Colak A., Karaoglan A., Barut S., et al. Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury. J Neurosurg Spine 2 (2005) 327-334
10. Crowe M.J., Bresnahan J.C., Shuman S.L., et al. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3 (1997) 73-76
11. Liu X.Z., Xu X.M., Hu R., et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 17 (1997) 5395-5406
12. Lou J., Lenke L.G., Ludwig F.J., et al. Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury. Spinal Cord 36 (1998) 683-690
13. Bresnahan J.C., Schuman S.L., and Beattie M.S. Evidence for apoptosis of oligodendroglia in long tracts undergoing wallerian degeneration after spinal cord injury (SCI) in monkeys. Soc Neurosci 22 (1996) 1185
14. Emery E., Aldana P., Bunge M.B., et al. Apoptosis after traumatic human spinal cord injury. J Neurosurg 89 (1998) 911-920
15. Charriaut-Marlangue C. Apoptosis: a target for neuroprotection. Therapie 59 (2004) 185-190
16. Ekert P.G., Silke J., and Vaux D.L. Caspase inhibitors. Cell Death Differ 6 (1999) 1081-1086
17. Fischer U., and Schulze-Osthoff K. Apoptosis-based therapies and drug targets. Cell Death Differ 12 Suppl.1 (2005) 942-961
18. Keane R.W., Kraydieh S., Lotocki G., et al. Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J Neuropathol Exp Neurol 60 (2001) 422-429
19. Lotocki G., and Keane R.W. Inhibitors of apoptosis proteins in injury and disease. IUBMB Life 54 (2002) 231-240
20. Nicholson D.W. From bench to clinic with apoptosis-based therapeutic agents. Nature 407 (2000) 810-816
21. Rudel T. Caspase inhibitors in prevention of apoptosis. Herz 24 (1999) 236-241
22. Villa P., Kaufmann S.H., and Earnshaw W.C. Caspases and caspase inhibitors. Trends Biochem Sci 22 (1997) 388-393
23. Lazaridis K.N., Gores G.J., and Lindor K.D. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. J Hepatol 35 (2001) 134-146
24. Rodrigues C.M., Fan G., Wong P.Y., et al. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 4 (1998) 165-178
25. Rodrigues C.M., Sola S., Brito M.A., et al. Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. Biochem Biophys Res Commun 281 (2001) 468-474
26. Castro R.E., Sola S., Ramalho R.M., et al. The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons. J Pharmacol Exp Ther 11 (2004) 845-852
27. Keene C.D., Rodrigues C.M., Eich T., et al. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc Natl Acad Sci USA 99 (2002) 10671-10676
28. Rodrigues C.M., Fan G., Ma X., et al. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 101 (1998) 2790-2799
29. Rodrigues C.M., Stieers C.L., Keene C.D., et al. Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition. J Neurochem 75 (2000) 2368-2379
30. Sola S., Amaral J.D., Borralho P.M., et al. Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid beta-peptide-induced apoptosis. Mol Endocrinol 20 (2006) 2292-2303
31. Rodrigues C.M., Spellman S.R., Sola S., et al. Neuroprotection by a bile acid in an acute stroke model in the rat. J Cereb Blood Flow Metab 22 (2002) 463-471
32. Rodrigues C.M., Sola S., Nan Z., et al. Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc Natl Acad Sci USA 100 (2003) 6087-6092
33. Allen A.R. Remarks on the histopathological changes in the spinal cord due to impact. An experimental study. J Nerv Ment Dis 41 (1914) 141-147
34. Rivlin A.S., and Tator C.H. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 47 (1977) 577-581
35. Tarlov I.M. Spinal Cord Compression: Mechanism of Paralysis and Treatment (1957), Charles C Thomas, Springfield. IL
36. Yong C., Arnold P.M., Zoubine M.N., et al. Apoptosis in cellular compartments of rat spinal cord after severe contusion injury. J Neurotrauma 15 (1998) 459-472
37. Argaud L., Gomez L., Gateau-Roesch O., et al. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury. J Mol Cell Cardiol 39 (2005) 893-899
38. Christophe M., and Nicolas S. Mitochondria: a target for neuroprotective interventions in cerebral ischemia-reperfusion. Curr Pharm Des 12 (2006) 739-757
39. Rodrigues C.M., Ma X., Linehan-Stieers C., et al. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ 6 (1999) 842-854
40. Rodrigues C.M., Sola S., Silva R., et al. Bilirubin and amyloid-beta peptide induce cytochrome c release through mitochondrial membrane permeabilization. Mol Med 6 (2000) 936-946
41. Xie Q., Khaoustov V.I., Chung C.C., et al. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology 36 (2002) 592-601
42. Tewari M., Quan L.T., O'Rourke K., et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81 (1995) 801-809
43. Zhang Y., McLaughlin R., Goodyer C., et al. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. J Cell Biol 156 (2002) 519-529
44. Mendoza M.E., Monte M.J., El-Mir M.Y., et al. Changes in the pattern of bile acids in the nuclei of rat liver cells during hepatocarcinogenesis. Clin Sci (Lond) 102 (2002) 143-150
45. Bossy-Wetzel E., and Green D.R. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 274 (1999) 17484-17490
46. Jiang S., Cai J., Wallace D.C., et al. Cytochrome c-mediated apoptosis in cells lacking mitochondrial DNA. Signaling pathway involving release and caspase 3 activation is conserved. J Biol Chem 274 (1999) 29905-29911